ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Optimizing CPRAs for Sensitized Kidney Waitlist Candidates: The Devil Is in the KAS Details.

J. Houp,1 R. Vega,1 B. Lonze,2 N. Desai,2 R. Montgomery,2 A. Jackson.1

1Medicine, Johns Hopkins University, Baltimore, MD
2Surgery, Johns Hopkins University, Baltimore, MD.

Meeting: 2016 American Transplant Congress

Abstract number: C196

Keywords: Allocation, Histocompatibility, HLA antibodies, Sensitization

Session Information

Session Name: Poster Session C: Kidney Transplantation: AKI/Preservation/DCD

Session Type: Poster Session

Date: Monday, June 13, 2016

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

The new kidney allocation system (KAS) has increased transplant rates for highly sensitized candidates. We hypothesized that increasing unacceptable antigens to transition candidates from 80-98% CPRA categories into the regional share 99% CPRA and national share 100% CPRA categories would increase the donor pool size and the opportunities for transplantation.

Kidney transplant data stratified by CPRA were analyzed during 3 time-periods: Prior to KAS (1/1/2014-12/31/2014); Post KAS1 using CDC crossmatch level HLA antibodies for unacceptable antigens (1/1/2015-4/30/2015) and Post-KAS2 using CDC and flow cytometric crossmatch level HLA antibodies to define unacceptable antigens (5/1/2015-12/1/2015).

Transplant rates were similar in the Pre-KAS and the Post-KAS1 period when using CDC crossmatch level HLA antibodies for determining unacceptable antigens. However, reducing this threshold and increasing unacceptable antigens for sensitized candidates increased transplants from 7 during Post-KAS1 (5 mo. period) to 42 during Post-KAS2 (6 mo. period). The number of transplants for 1-79% CPRA candidates increased from 6 to 12, for the 80%-98% CPRA candidates the increase was from 1 to 7, and the largest increase was for 100% CPRA candidates from 0 to 23. No transplants occurred within the 99% CPRA category during any Post-KAS period despite increasing the potential donor pool size with regional share policies. This disadvantage for 99% CPRA candidates was also observed in the 6 month National KAS Report; transplant rates for 100% CPRA candidates increased ten-fold ( 1.0 to 11.2%) compared to the three-fold (1.3% to 3.7%) increase for 99% CPRA candidates. This disadvantage likely arises from competition between 99% and 100% CPRA candidates for donors with unique HLA phenotypes. Compatible donors for 99% CPRA candidates are infrequent and are likely allocated to 100% CPRA candidates at the local, regional, and national levels before becoming available to 99% CPRA candidates at the regional level.

Additional CPRA allocation points increase transplant opportunities for 1-98% CPRA candidates within the local donor pool and transitioning candidates into the 100% CPRA category allows access to a larger national donor pool. However, candidates with 99% CPRAs may be disadvantaged if the size of the local and regional donor pools is insufficient for finding compatible donors.

CITATION INFORMATION: Houp J, Vega R, Lonze B, Desai N, Montgomery R, Jackson A. Optimizing CPRAs for Sensitized Kidney Waitlist Candidates: The Devil Is in the KAS Details. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Houp J, Vega R, Lonze B, Desai N, Montgomery R, Jackson A. Optimizing CPRAs for Sensitized Kidney Waitlist Candidates: The Devil Is in the KAS Details. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/optimizing-cpras-for-sensitized-kidney-waitlist-candidates-the-devil-is-in-the-kas-details/. Accessed May 9, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences